Multimodal Characterization of APOE ε4-Associated Neurovascular Heterogeneity Using Retinal, Plasma, and Neuroimaging Biomarkers in Alzheimer's Disease.
5 affiliations
- 1Department of Geriatrics, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
- 2Department of Neurology, Sir Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
- 3Department of Neurology, West China Hospital, Sichuan University, Chengdu, China.
- 4Neurology Department, Xuanwu Hospital, Capital Medical University, Beijing, China.
- 5Department of Radiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Abstract
Background
Biological heterogeneity remains a major challenge in Alzheimer's disease (AD), even among individuals with biomarker-confirmed disease. The apolipoprotein E (APOE) ε4 allele is associated with greater amyloid burden, neurodegeneration, and vascular dysfunction. We investigated whether retinal microvascular imaging provides complementary information beyond plasma and neuroimaging biomarkers for characterizing APOE ε4-associated neurovascular heterogeneity in biologically defined AD.Methods
Eighty-four amyloid-positive patients with AD underwent color fundus photography, swept-source optical coherence tomography angiography (OCTA), plasma biomarker assessment, amyloid positron emission tomography, and magnetic resonance imaging. Retinal vascular parameters were compared between APOE ε4 carriers and non-carriers using generalized estimating equations. Candidate multimodal biomarkers were identified using least absolute shrinkage and selection operator (LASSO) regression, followed by multivariable logistic regression to evaluate the incremental contribution of retinal biomarkers within a multimodal phenotyping model.Results
Compared with non-carriers, APOE ε4 carriers demonstrated significantly lower retinal superficial vascular complex (SVC) and deep vascular complex densities, reduced retinal vascular fractal dimension, higher amyloid PET standardized uptake value ratios, increased peak width of skeletonized mean diffusivity, and smaller hippocampal volumes (all p < 0.05). Following penalized feature selection, retinal SVC density remained independently associated with APOE ε4 status alongside amyloid burden, hippocampal volume, and white matter microstructural injury. Incorporation of SVC modestly improved discrimination and calibration of the multimodal model compared with neuroimaging biomarkers alone.Conclusions
Retinal microvascular alterations are associated with APOE ε4-related biological heterogeneity in biomarker-confirmed AD. Retinal vascular imaging provides complementary information beyond established plasma and neuroimaging biomarkers and may enhance multimodal characterization of neurovascular phenotypes rather than serve as a surrogate for genetic testing.
Related
- Multimodal neuroimaging signature of sleep problems captures preadolescent mental health trajectories
- Multimodal neuroimaging and electrophysiological signatures in amnestic mild cognitive impairment with different amyloid-β deposition status: correlations with cognitive function and diagnostic value
- Multimodal neuroimaging of cue-induced craving and cortical alterations in etomidate use disorder
- Neurovascular uncoupling in type 2 diabetes mellitus: multimodal MRI reveals the association between hippocampal and subcortical structures dysfunction and cognitive decline
- Multimodal EEG-fNIRS complexity analysis can reveal the neurovascular coupling change with aging
BibTeX
@article{cheng2026multimodal,
title = {{Multimodal Characterization of APOE ε4-Associated Neurovascular Heterogeneity Using Retinal, Plasma, and Neuroimaging Biomarkers in Alzheimer's Disease.}},
author = {Haoran Cheng and Huwei Xia and Youjie Wang and Le Cao and Suqing Hu and Huayan Wang and William Robert Kwapong and Zhen Wang and Caiyun Wen},
journal = {CNS neuroscience \& therapeutics},
year = {2026},
month = oct,
doi = {10.1002/cns.71220},
url = {https://europepmc.org/article/MED/42921695},
note = {CC BY},
}
RIS
TY - JOUR
TI - Multimodal Characterization of APOE ε4-Associated Neurovascular Heterogeneity Using Retinal, Plasma, and Neuroimaging Biomarkers in Alzheimer's Disease.
AU - Haoran Cheng
AU - Huwei Xia
AU - Youjie Wang
AU - Le Cao
AU - Suqing Hu
AU - Huayan Wang
AU - William Robert Kwapong
AU - Zhen Wang
AU - Caiyun Wen
PY - 2026
DA - 2026/10/01
JO - CNS neuroscience & therapeutics
DO - 10.1002/cns.71220
UR - https://europepmc.org/article/MED/42921695
AB - Background Biological heterogeneity remains a major challenge in Alzheimer's disease (AD), even among individuals with biomarker-confirmed disease. The apolipoprotein E (APOE) ε4 allele is associated with greater amyloid burden, neurodegeneration, and vascular dysfunction. We investigated whether retinal microvascular imaging provides complementary information beyond plasma and neuroimaging biomarkers for characterizing APOE ε4-associated neurovascular heterogeneity in biologically defined AD.Methods Eighty-four amyloid-positive patients with AD underwent color fundus photography, swept-source optical coherence tomography angiography (OCTA), plasma biomarker assessment, amyloid positron emission tomography, and magnetic resonance imaging. Retinal vascular parameters were compared between APOE ε4 carriers and non-carriers using generalized estimating equations. Candidate multimodal biomarkers were identified using least absolute shrinkage and selection operator (LASSO) regression, followed by multivariable logistic regression to evaluate the incremental contribution of retinal biomarkers within a multimodal phenotyping model.Results Compared with non-carriers, APOE ε4 carriers demonstrated significantly lower retinal superficial vascular complex (SVC) and deep vascular complex densities, reduced retinal vascular fractal dimension, higher amyloid PET standardized uptake value ratios, increased peak width of skeletonized mean diffusivity, and smaller hippocampal volumes (all p < 0.05). Following penalized feature selection, retinal SVC density remained independently associated with APOE ε4 status alongside amyloid burden, hippocampal volume, and white matter microstructural injury. Incorporation of SVC modestly improved discrimination and calibration of the multimodal model compared with neuroimaging biomarkers alone.Conclusions Retinal microvascular alterations are associated with APOE ε4-related biological heterogeneity in biomarker-confirmed AD. Retinal vascular imaging provides complementary information beyond established plasma and neuroimaging biomarkers and may enhance multimodal characterization of neurovascular phenotypes rather than serve as a surrogate for genetic testing.
SN - 1755-5930
SN - 1755-5949
ER -